Previous Article | Next Article ![]()
Journal of Bacteriology, August 2002, p. 4301-4303, Vol. 184, No. 15
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.15.4301-4303.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Departmento de Biologíia Molecular, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, 5.800 Río Cuarto,1 Departamento de Química Biológica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 5000 Córdoba, Argentina2
Received 21 December 2001/ Accepted 30 April 2002
|
|
|---|
|
|
|---|
Isolation and characterization of the TN5::751 mutant of P. aeruginosa. To identify the locus required for the utilization of glycine betaine as a carbon and nitrogen source in P. aeruginosa, strain PRS (a streptomycin-resistant [Strr] derivative of the wild-type strain Fildes III) was subjected to random mutagenesis with the Tn5::751 transposon, encoding kanamycin resistance (Kmr) and trimethoprim resistance (Tpr) (8). Approximately 3,200 colonies capable of growing in nutritive medium with streptomycin, kanamycin, and trimethoprim (1,000, 250, and 500 µg · ml-1, respectively) were screened for growth on iso-osmolar high-phosphate basal salt medium (HPi-BSM) (7) containing succinate plus NH4Cl or on choline as a carbon and nitrogen source. One strain that did not grow on choline was selected and designated ALS-96. Studies of growth on plates, subsequently confirmed to occur in liquid media (Table 1), showed that this strain was not capable of growing on either choline or glycine betaine under iso-osmolar or hyperosmolar conditions. Nevertheless, its growth was similar to that of the wild-type strain on succinate-NH4Cl or on choline derivatives such as DMG or sarcosine. The doubling times obtained under iso-osmolar and hyperosmolar conditions were similar to those obtained previously with the wild-type strain (Table 1). Given that the inability of ALS-96 to grow on choline may be due to a failure to take up choline or an incapacity to metabolize choline to glycine betaine, we performed studies with HPi-BSM-succinate-NH4Cl hyperosmolar medium with the addition of 1 mM exogenous [methyl-14C]choline as an osmoprotectant. Under such osmotic-stress conditions, both the mutant and the wild-type strains grew similarly (data not shown), thus confirming the integrity of the uptake system. In addition, the metabolic transformation of choline was confirmed by thin-layer chromatography analysis, since glycine betaine was the main labeled soluble osmoprotector extracted from strain ALS-96 (Fig. 1, lane 3), as was earlier demonstrated for the wild-type strain (2).
|
View this table: [in a new window] |
TABLE 1. Growth and doubling times of the P. aeruginosa PRS and ALS-96 strains under iso-osmolar and hyperosmolar culture conditions
|
![]() View larger version (60K): [in a new window] |
FIG. 1. Fate of [methyl-14C]choline. The ALS-96 mutant strain was grown to the mid-exponential phase (optical density at 600 nm, 0.5) in hyperosmolar HPi-BSM medium with 1 mM choline-[methyl-14C]choline as the osmoprotectant. Cells were harvested and treated as described previously (2). Soluble metabolites were analyzed by thin-layer chromatography (methanol-NH4OH, 75:25 [0.8 M]). The radiolabeled compounds were visualized by autoradiography. Lane 1, [methyl-14C]choline as a standard; lane 2, [methyl-14C]glycine betaine as a standard; lane 3, ALS-96 extract.
|
Localization and cloning of the DNA fragment affected by the TN5::751 insertion and complementation of the mutant strain by wild-type.
Southern hybridization experiments revealed a single insertion of Tn5::751 in the genome of the mutant strain ALS-96. A SalI restriction site was found 2.1 kb from the left border of the Tn5::751 insertion (Fig. 2). Digestion of Tn5::751 with SalI separates the two resistance gene markers (Km and Tp) (Fig. 2A). The total DNA of the mutant strain ALS-96 was digested with SalI, and the resulting DNA was purified and ligated into the ampicillin-resistant (Apr) pBluescript II SK plasmid, digested with the same enzyme, and used to transform Escherichia coli DH5
. Ten identical Apr and Kmr clones were obtained, and one was selected for further studies. The transformant E. coli strain carried a recombinant plasmid named pJM1 (8.0 kb) that had a 4.8-kb insert carrying the Kmr marker (2.7 kb) and the P. aeruginosa DNA adjacent to it (2.1 kb).
![]() View larger version (15K): [in a new window] |
FIG. 2. (A) Restriction map of the region of DNA around the inactivated gbt gene by insertion of Tn5::751 in the genome of P. aeruginosa Fildes III. The locations of PA3081, PA3082, and pepN (PA3083) are also shown in the complete genome of P. aeruginosa PAO1 published previously (10). (B) The 4.8-kb SalI-SalI DNA fragment containing the 2.1 kb of genomic DNA adjacent to the 2.7 kb of Tn5::751, which contains IS50L and the kanamycin resistance marker is shown.
|
Plasmids p5-orf1 and p5-orf3 were mobilized to P. aeruginosa ALS-96 by conjugation (3). Colonies capable of growing on Luria-Bertani agar with TMP, KAN, and GEN (500, 200, and 20 µg · ml-1, respectively) were selected and tested for their capacity to grow on HPi-BSM medium with glycine betaine as the sole carbon and nitrogen source. All transconjugants degraded glycine betaine. This result clearly shows that the corresponding wild-type DNA included in the p5-orf3 plasmid was sufficient to complement the mutation.
The corresponding knockout gene was named gbt for glycine betaine transmethylase. The gbt nucleotide sequence has a G+C content of 64.8%, which is typical for the genes of P. aeruginosa (11). The corresponding translated protein, GBT, would contain 548 amino acid residues. Comparison of this ORF product with sequences in the GenBank database (BLASTP) (1) showed sequence similarity with different transferases, like a putative O-methyltransferase (PKSA) of Streptomyces collinus (29% identity and 36% similarity; E = 3e-11) (GenBank accession no. AF293354), with a uridylyl transferase of P. aeruginosa PAO1 (27% identity and 34% similarity; E = 1e-07) (accession no. AB024601), and with an adenylyltransferase of Chlamydomonas reinhardtii (32% identity and 39% similarity; E = 1e-06) (accession no. X91736). The ClustalW alignment of sequences from GBT and O-methyltransferase of S. collinus does not show a specific conserved domain, but the homology between them is extended over the entire protein.
In conclusion, the results of this study strongly suggest that P. aeruginosa ALS-96 is impaired in GBT activity but not in either the production of glycine betaine from choline or the uptake of choline from the culture medium. The complementation test described above confirms that the P. aeruginosa ALS-96 phenotype was clearly due to the presence of a Tn5::751 insertion in the gbt sequence located within the ORF that corresponded to PA3082 in the unmutated genome of P. aeruginosa PAO1. Although the gbt gene is unlinked to those genes involved in the first steps of choline utilization (10), all of them may be coordinately regulated in response to the osmotic conditions of the culture.
Financial support was provided by the Universidad Nacional de Río Cuarto, Agencia Córdoba Ciencia de la Provincia de Córdoba, and CONICET, all of the Republica Argentina. J.L.B., C.E.D., and A.T.L. are Career Members of the CONICET.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»